Los Angeles Capital Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
VPM
VCM
Los Angeles Capital Management's TWST Position: Q1 2026 in Review
Los Angeles Capital Management reduced its Twist Bioscience (TWST) stake by 95% in Q1 2026, selling an estimated $337K and leaving 376 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1775.
Los Angeles Capital Management first reported a position in TWST in Q1 2020 and has held it in 23 quarters since. The position peaked at $1.33M in Q4 2020. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.
- Los Angeles Capital Management held 376 shares of Twist Bioscience worth $17.9K as of Q1 2026.
- Los Angeles Capital Management sold 7,508 Twist Bioscience shares in Q1 2026, an estimated $337K.
- Twist Bioscience made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1775 holding.
- Los Angeles Capital Management first reported a position in Twist Bioscience in Q1 2020 and has held it in 23 quarters since.
- Los Angeles Capital Management's Twist Bioscience position peaked at $1.33M in Q4 2020.
- 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.